AccuLine

AccuLine is transforming cardiac care with accessible, AI-powered diagnostics for early detection of coronary artery disease.

Health Tech
Active
Pre-Seed Petah Tikva, Israel Founded 2022
Last updated 2026-09-04
Total raised
$4.2M
Last: Seed 2024-07
Stage
Pre-Seed
Founded
2022
Headcount
7
HQ
Petah Tikva, Israel
Sector
Health Tech

About

AccuLine is a medical device startup founded with the vision to save millions of lives worldwide by preventing the next heart attack. AccuLine is developing CORA, an accurate, non-invasive, and cost-effective system for the early detection of coronary artery disease (CAD), aiming to replace inaccurate, time-consuming, and labor-intensive stress test exams. CORA uses advanced signal filtering and deep learning algorithms to analyze three biological signals: the heart's electrical function, oxygen saturation, and breathing phase, providing immediate, actionable results without radiation or contrast agents.

Funding history · 1 round · $4.2M total

1 event/round · $4.2M Total Funding: $4.2M in Private Equity
Jul 2024
★ Mayo Clinic★ eHealth Ventures★ Google's AI Startups Fund★ Maccabi Healthcare Services★ Israel Innovation Authority

Headcount over time

7 employees (2026-09) · 1 point
7 7 2026-09

Offices

Petah Tikva, Israel · HQ / main office

Q&A

What is AccuLine's primary focus?
AccuLine is a medical device startup focused on transforming cardiac care with accessible, AI-powered diagnostics for the early detection of coronary artery disease (CAD).
What is the name of AccuLine's core product?
AccuLine is developing CORA, a system designed for the early detection of coronary artery disease (CAD).
How does AccuLine's CORA system work?
CORA uses advanced signal filtering and deep learning algorithms to analyze three biological signals: the heart's electrical function, oxygen saturation, and breathing phase, providing immediate, actionable results without radiation or contrast agents.
When was AccuLine founded?
AccuLine was founded in February 2022.
What was AccuLine's most recent funding round?
In July 2024, AccuLine completed a Seed funding round, raising $4,200,000. Investors included eHealth Ventures and Maccabi Healthcare Services.
Which organizations provided grants to AccuLine in May 2024?
In May 2024, AccuLine received a grant of $600,000 from Google and the Israel Innovation Authority.
What strategic agreement did AccuLine announce in September 2023?
In September 2023, AccuLine announced a Know-How License Agreement with Mayo Clinic to advance the early detection of heart attacks.
Who are the co-founders of AccuLine?
The co-founders of AccuLine are Moshe Barel (CEO), Prof. Aharon Frimerman (CMO), and Prof. Shai Revzen (CSO).

Team · 13

Moshe Barel
Founder · CEO & Co-Founder
Prof. Aharon Frimerman
Founder · CMO & Co-Founder
Prof. Shai Revzen
Founder · CSO & Co-Founder
Benny Shani
Founder · CTO & Co-Founder
Dr. Amit Reches
CTO
Don Crawford
CBO
Yuliya Zadka
Director Of Clinical Affairs
Tamar Reitich-Stolero
Director Of Data Science
Joe Mullings
Advisory Board
Prof. Timothy Henry
Advisory Board
Prof. Gad Keren
Advisory Board
Prof. Thomas Thacher
Advisory Board
Prof. Brian Olshansky
Advisory Board

Sectors & technology

Primary sector
Health Tech
Technologies
Target customers
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-devicespreventionmachine-learningearly-detectionheart-failurealgorithmsartificial-intelligencenon-invasivedigital-healthcarediagnosticscardiovascularhealthcaresignal-processingcardiology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteacculine-medical.com
LinkedInlinkedin.com/company/82039359

Identifiers & details

Founded2022-2
Employees (exact)7

Radar intelligence

Patents

EPO9

Web history (Wayback)

Domainacculine-medical.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516557170
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2022-02-09
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens1
Registry events5 — shares_capital (2), charge (1), other (1), people (1)
Registered addressרפאל איתן 2 פתח תקווה

Recent registry events

DateEvent
2025-10-23העברת מניות
2025-10-23הקצאת מניות
2026-04-23רישום שעבוד
2025-11-13שינוי בתקנון
2025-11-12עדכון דירקטורים-הסרת דירקטור